Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges.


Journal

Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456

Informations de publication

Date de publication:
2021
Historique:
received: 04 11 2020
accepted: 15 12 2020
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 7 2 2021
Statut: epublish

Résumé

Covid-19 is a novel infectious disease whose spectrum of presentation ranges from absence of symptoms to widespread interstitial pneumonia associated with severe acute respiratory syndrome (SARS), leading to significant mortality. Given the systemic pattern of Covid-19, there are many factors that can influence patient's functional capacity after acute infection and the identification of such factors can contribute to the development of specific rehabilitation strategies. Pulmonary impairment is the primary cause of hospitalization due to Covid-19, and can progress to SARS as well as increase length of hospitalization. Moreover, cardiac involvement is observed in approximately 30% of hospitalized patients, with an increased risk of acute myocarditis, myocardial injury, and heart failure, which may compromise functional capacity in the long-term. Thromboembolic complications have also been reported in some patients with Covid-19 and are associated with a poor prognosis. Musculoskeletal complications may result from long periods of hospitalization and immobility, and can include fatigue, muscle weakness and polyneuropathy. Studies that address the functional capacity of patients after Covid-19 infection are still scarce. However, based on knowledge from the multiple systemic complications associated with Covid-19, it is reasonable to suggest that most patients, especially those who underwent prolonged hospitalization, will need a multiprofessional rehabilitation program. Further studies are needed to evaluate the functional impact and the rehabilitation strategies for patients affected by Covid-19.

Identifiants

pubmed: 33533821
pii: S0037-86822021000100200
doi: 10.1590/0037-8682-0789-2020
pmc: PMC7849325
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e07892020

Références

Heart. 2019 Apr;105(7):510-515
pubmed: 30700518
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124
pubmed: 32387623
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824
pubmed: 32249102
Otolaryngol Head Neck Surg. 2021 Feb;164(2):294-296
pubmed: 32806993
Rev Bras Ter Intensiva. 2020 Jun;32(2):197-199
pubmed: 32667446
CMAJ. 2020 Jul 6;192(27):E756-E767
pubmed: 32409522
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Codas. 2020 Oct 07;32(4):e20200222
pubmed: 33053075
Arq Bras Cardiol. 2020 May 11;114(5):805-816
pubmed: 32401847
Eur J Phys Rehabil Med. 2020 Dec;56(6):846-852
pubmed: 33118719
Drug Saf. 2020 Aug;43(8):699-709
pubmed: 32572842
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Eur J Phys Rehabil Med. 2020 Oct;56(5):642-651
pubmed: 32705860
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Front Public Health. 2020 Jul 29;8:383
pubmed: 32850602
J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008
pubmed: 32270559
BMJ. 2020 Jul 30;370:m2922
pubmed: 32732337
Science. 2020 Jul 3;369(6499):11
pubmed: 32631871
Arq Bras Cardiol. 2020 Jun 1;114(5):943-987
pubmed: 32491079
Rev Assoc Med Bras (1992). 2020 May 15;66(2):116-123
pubmed: 32428144
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Med Sci Monit. 2019 Jul 12;25:5159-5169
pubmed: 31296834
Physiotherapy. 2011 Dec;97(4):284-90
pubmed: 22051584
J Clin Med Res. 2012 Feb;4(1):7-16
pubmed: 22383921
Eur Respir J. 2020 Oct 15;56(4):
pubmed: 32764112
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Respir Care. 2020 Apr;65(4):437-443
pubmed: 31641072
Eur Heart J. 2020 Oct 14;41(39):3836-3838
pubmed: 33006608
Obes Res Clin Pract. 2020 May - Jun;14(3):210-216
pubmed: 32460966
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
Circulation. 2019 Oct 15;140(16):1293-1295
pubmed: 31609661
Eur J Phys Rehabil Med. 2020 Oct;56(5):633-641
pubmed: 32667150
Clinics (Sao Paulo). 2020 Jun 12;75:e2021
pubmed: 32555948
Cad Saude Publica. 2020;36(5):e00072020
pubmed: 32428076
Chin Med J (Engl). 2020 Jul;133(13):1595-1602
pubmed: 32251002
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
J Am Heart Assoc. 2020 Sep 15;9(18):e016807
pubmed: 32806998
Am J Phys Med Rehabil. 2020 Jun;99(6):470-474
pubmed: 32282359
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):525-535
pubmed: 32794002
J Bras Pneumol. 2020;46(4):e20200168
pubmed: 32490908
Rev Bras Ter Intensiva. 2015 Apr-Jun;27(2):161-9
pubmed: 26340157
Eur J Prev Cardiol. 2020 Aug;27(12):1242-1251
pubmed: 32475157
Lancet Haematol. 2020 Jun;7(6):e425
pubmed: 32470428
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Einstein (Sao Paulo). 2020 Jun 03;18:eAI5750
pubmed: 32520072
Diabetes Metab Syndr. 2020 May - Jun;14(3):247-250
pubmed: 32247212
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
J Transl Med. 2020 Jun 8;18(1):229
pubmed: 32513197
Br J Sports Med. 2020 Aug;54(16):949-959
pubmed: 32475821
Physiotherapy. 2013 Mar;99(1):33-41
pubmed: 23219649
Rev Panam Salud Publica. 2020 Mar 20;44:e40
pubmed: 32256547
Prog Cardiovasc Dis. 2020 May - Jun;63(3):386-388
pubmed: 32220590
Rev Bras Ter Intensiva. 2020 Mar;32(1):58-65
pubmed: 32401991
Postgrad Med J. 2021 May;97(1147):312-320
pubmed: 32978337
Eur Heart J. 2020 Oct 14;41(39):3827-3835
pubmed: 32968776
Int J Gastron Food Sci. 2020 Oct;21:100226
pubmed: 32528560
J Laryngol Otol. 2020 Aug;134(8):703-709
pubmed: 32782030
Am J Phys Med Rehabil. 2020 Aug;99(8):669-673
pubmed: 32467492
J Infect Dis. 2020 Nov 9;222(11):1807-1815
pubmed: 32914853
Eur J Phys Rehabil Med. 2021 Feb;57(1):171-172
pubmed: 32891080
Infect Drug Resist. 2020 Jul 29;13:2631-2635
pubmed: 32801800
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Rev Bras Ter Intensiva. 2019 Oct-Dec;31(4):555-560
pubmed: 31967232
Eur J Phys Rehabil Med. 2020 Jun;56(3):347-353
pubmed: 32316718
Thromb Res. 2020 Aug;192:152-160
pubmed: 32485418
JAMA. 2020 Nov 3;324(17):1723-1724
pubmed: 33031513
Int J Cardiol. 2013 Aug 20;167(4):1502-7
pubmed: 22560934
Braz Oral Res. 2020 May 8;34:e041
pubmed: 32401931
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Rev Bras Ter Intensiva. 2018 Mar;30(1):57-63
pubmed: 29742218
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32381497

Auteurs

Aline Xavier Frota (AX)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Marcelo Carvalho Vieira (MC)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Carla Cristiane Santos Soares (CCS)

Instituto Nacional de Cardiologia, Departamento de Pesquisa e Educação, Rio de Janeiro, RJ, Brasil.

Paula Simplício da Silva (PSD)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Gilberto Marcelo Sperandio da Silva (GMSD)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Fernanda de Souza Nogueira Sardinha Mendes (FSNS)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Flavia Mazzoli-Rocha (F)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Henrique Horta Veloso (HH)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Ananda Dutra da Costa (ADD)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.

Cristiane da Cruz Lamas (CDC)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Cardiologia, Departamento de Pesquisa e Educação, Rio de Janeiro, RJ, Brasil.

Claudia Maria Valete-Rosalino (CM)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro, Departamento de Otorrinolaringologia e Oftalmologia, Rio de Janeiro, RJ, Brasil.
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Programa de Produtividade em Pesquisa, Brasília, DF, Brasil.

Tatiana Rehder Gonçalves (TR)

Universidade Federal do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brasil.

Henrique Silveira Costa (HS)

Universidade Federal dos Vales do Jequitinhonha e Mucuri, Departamento de Fisioterapia, Diamantina, MG, Brasil.

Luiz Fernando Rodrigues Junior (LF)

Instituto Nacional de Cardiologia, Departamento de Pesquisa e Educação, Rio de Janeiro, RJ, Brasil.
Universidade Federal do Estado do Rio de Janeiro, Departamento de Ciências Fisiológicas, Rio de Janeiro, RJ, Brasil.

Mauro Felippe Felix Mediano (MFF)

Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Cardiologia, Departamento de Pesquisa e Educação, Rio de Janeiro, RJ, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH